Tempe, AZ, United States of America

Christopher W Diehnelt

This inventor holds 3 USPTO granted patents and 9 published patent applications. Top assignee: Arizona State University. Active years: 2013-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher W Diehnelt. Retrieved from https://idiyas.com/inventor/christopher-w-diehnelt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 16(Granted Patents)


Location History:

  • Tempe, AZ (US) (2013)
  • Chandler, AZ (US) (2018)

Company Filing History:


Years Active: 2013-2018

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Christopher W Diehnelt: Innovator in Synthetic Antibodies

Introduction

Christopher W Diehnelt is a prominent inventor based in Tempe, AZ (US). He has made significant contributions to the field of synthetic antibodies, holding a total of 3 patents. His work focuses on developing innovative solutions for binding influenza and creating synthetic antibodies.

Latest Patents

Diehnelt's latest patents include "High Affinity Synbodies for Influenza," which describes a composition of synbodies that effectively bind to influenza. These synbodies are composed of two peptides joined on a scaffold. Another notable patent is "Synthetic Antibodies," which outlines methods for synthetic antibodies, methods for making synthetic antibodies, and methods for identifying ligands, along with related methods and reagents.

Career Highlights

Christopher W Diehnelt is affiliated with Arizona State University, where he continues to advance research in synthetic antibodies. His innovative work has garnered attention in the scientific community, contributing to the understanding and development of synthetic antibody technologies.

Collaborations

Diehnelt has collaborated with notable colleagues, including Stephen Albert Johnston and Valeriy Domenyuk, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Christopher W Diehnelt is a key figure in the field of synthetic antibodies, with a focus on innovative solutions for influenza and antibody development. His contributions are shaping the future of this important area of research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…